Tamada Nao, Tojo Kentaro, Yazawa Takuya, Goto Takahisa
Department of Anesthesiology and Critical Care Medicine, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan.
Department of Pathology, Dokkyo Medical University, Mibu, Tochigi, Japan.
Shock. 2020 Jul;54(1):128-139. doi: 10.1097/SHK.0000000000001425.
Alveolar epithelial cell (AEC) death, which is classified as apoptosis or necrosis, plays a critical role in the pathogenesis of acute respiratory distress syndrome (ARDS). In addition to apoptosis, some types of necrosis are known to be molecularly regulated, and both apoptosis and necrosis can be therapeutic targets for diseases. However, the relative contribution of apoptosis and necrosis to AEC death during ARDS has not been elucidated. Here, we evaluated which type of AEC death is dominant and whether regulated necrosis is involved in lipopolysaccharide (LPS)-induced lung injury, an experimental ARDS model. In the bronchoalveolar lavage fluid from the LPS-induced lung injury mice, both the levels of cytokeratin 18-M65 antigen (a marker of total epithelial cell death) and cytokeratin 18-M30 antigen (an epithelial apoptosis marker) were increased. The M30/M65 ratio, which is an indicator of the proportion of apoptosis to total epithelial cell death, was significantly lower than that in healthy controls. In addition, the number of propidium iodide-positive, membrane-disrupted cells was significantly higher than the number of TUNEL-positive apoptotic cells in the lung sections of lung injury mice. Activated neutrophils seemed to mediate AEC death. Finally, we demonstrated that necroptosis, a regulated necrosis pathway, is involved in AEC death during LPS-induced lung injury. These results indicate that necrosis including necroptosis, rather than apoptosis, is the dominant type of AEC death in LPS-induced lung injury. Although further studies investigating human ARDS subjects are necessary, targeting necrosis including its regulated forms might represent a more efficient approach to protecting the alveolar epithelial barrier during ARDS.
肺泡上皮细胞(AEC)死亡分为凋亡或坏死,在急性呼吸窘迫综合征(ARDS)的发病机制中起关键作用。除凋亡外,已知某些类型的坏死也受分子调控,且凋亡和坏死都可能成为疾病的治疗靶点。然而,ARDS期间凋亡和坏死对AEC死亡的相对贡献尚未阐明。在此,我们评估了哪种类型的AEC死亡占主导地位,以及在脂多糖(LPS)诱导的肺损伤(一种实验性ARDS模型)中是否涉及程序性坏死。在LPS诱导的肺损伤小鼠的支气管肺泡灌洗液中,细胞角蛋白18-M65抗原(总上皮细胞死亡标志物)和细胞角蛋白18-M30抗原(上皮细胞凋亡标志物)的水平均升高。M30/M65比值是凋亡占总上皮细胞死亡比例的指标,显著低于健康对照。此外,在肺损伤小鼠的肺切片中,碘化丙啶阳性、细胞膜破裂的细胞数量显著高于TUNEL阳性凋亡细胞数量。活化的中性粒细胞似乎介导了AEC死亡。最后,我们证明程序性坏死(一种程序性坏死途径)参与了LPS诱导的肺损伤期间的AEC死亡。这些结果表明,包括程序性坏死在内的坏死而非凋亡是LPS诱导的肺损伤中AEC死亡的主要类型。尽管有必要对人类ARDS受试者进行进一步研究,但针对包括其程序性形式在内的坏死进行靶向治疗可能是在ARDS期间保护肺泡上皮屏障的更有效方法。